# Puhui Brilliance Fund

Puhui Brilliance Fund is an Asset Manager based in Beijing, China.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Beijing, China
- **Region:** Asia
- **Address:** Beijing, China
- **Assets under management:** Undisclosed

## Regulatory record

- **Reports private funds:** No

## About

Puhui Brilliance Fund is a Beijing-based investment company that employs a Venture Capital strategy.

## Sectors

- Healthcare
- Venture Capital

## People

- Zhe Ji — Founder, Chairman, and CEO

## Questions

### Who controls investment decisions at Puhui Brilliance Fund?

Zhe Ji, as Founder, Chairman, and CEO of parent entity Puhui Wealth Investment Management, maintained investment authority over the fund's venture allocations. A broader investment committee has not been disclosed in public filings.

### How did the fund source its healthcare investments?

The fund sourced deals domestically within China, leveraging the parent company's VIE structure and onshore network to identify healthcare companies seeking cross-border capital. Specific sourcing channels, including any formal incubator or hospital-system partnerships, have not been publicly detailed.

### What was the relationship between Puhui Brilliance Fund and Longevity Acquisition Corporation?

Longevity Acquisition Corporation was an affiliated SPAC sponsored by entities related to Puhui Wealth Investment Management. It functioned as a designated exit vehicle, targeting high-growth companies — including those within Puhui's pipeline — for Nasdaq listings via de-SPAC business combinations.

### Is Puhui Brilliance Fund still actively investing?

The firm's operational status is opaque. Its parent, Puhui Wealth Investment Management, faced financial distress and regulatory headwinds beginning in 2021 as China moved to restrict VIE-based wealth management structures. The fund's current deal-making posture is unclear.

### What regulatory risk was embedded in Puhui's structure?

Puhui's reliance on a VIE structure for domestic operations combined with a US-listed SPAC exit vehicle placed it directly in the path of two regulatory crackdowns: China's prohibition on new VIE formations for asset management and tightened oversight of offshore listings, both of which materially constrained the fund's strategic playbook after 2021.

## Related profiles

- [Puhui Zhengtong Capital](https://altss.com/profile/puhui-zhengtong-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/puhui-brilliance-fund

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology